Petrichor Biologics Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Petrichor Biologics General Information
Description
Developer of biological and pharmaceutical technologies designed to improve human and environmental health. The company specializes in health technology development, disease prevention, therapeutic development, environmental health research, and health management technologies, enabling healthcare organizations and researchers to improve treatment approaches and manage health needs effectively.
Contact Information
Website
www.pertichorbiologics.inCorporate Office
- B-273a, F-3, Ramprasth
- Ghaziabad, Uttar Pradesh 201011
- India
Corporate Office
- B-273a, F-3, Ramprasth
- Ghaziabad, Uttar Pradesh 201011
- India
Petrichor Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 02-Sep-2021 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Petrichor Biologics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sharda Launchpad | Accelerator/Incubator |
Petrichor Biologics FAQs
-
Where is Petrichor Biologics headquartered?
Petrichor Biologics is headquartered in Ghaziabad, India.
-
What industry is Petrichor Biologics in?
Petrichor Biologics’s primary industry is Drug Discovery.
-
Is Petrichor Biologics a private or public company?
Petrichor Biologics is a Private company.
-
What is Petrichor Biologics’s current revenue?
The current revenue for Petrichor Biologics is .
-
Who are Petrichor Biologics’s investors?
Sharda Launchpad has invested in Petrichor Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process